VIVA Physicians to Hold Forum on Drug Elution in Peripheral Artery Disease


December 14, 2018—With the recent concerns centered around drug-eluting devices and peripheral arterial disease, VIVA Physicians, a 501(c)3 not-for-profit organization dedicated to education and research in vascular medicine and intervention, announces its plan for an international forum to discuss “Drug Elution in Peripheral Artery Disease: A Critical Analysis From a Multispecialty Consortium.”

Thought leaders from around the world with recognized expertise in peripheral vascular intervention will be invited, along with representatives from the major medical societies, the commercial medical device sector, United States regulatory and reimbursement agencies, as well as patient advocates, to attend a 1.5-day event in Washington DC. This event is targeted for February 2019.

The goal of this forum is to analyze and debate the efficacy and safety of specific categories of minimally invasive, catheter-based interventions. Funding for this consortium will be provided solely by VIVA.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.